BioTalk Unzipped

About BioTalk Unzipped

BioTalk Unzipped, hosted by Gregory Austin and Dr. Chad Briscoe, unzips the stories behind medical progress through candid, intelligent, and often entertaining conversations with leaders across biotechnology, pharmaceuticals, medical technology, clinical research, bioanalysis, and drug development. Each episode explores the science, strategy, setbacks, breakthroughs, and human stories shaping the future of medicine. From first-in-human trials and biomarkers to oncology, rare disease, AI, regulatory strategy, and emerging therapeutic technologies, BioTalk Unzipped makes complex life science topics engaging, accessible, and relevant. The show feels like the conversation you would want to overhear after a great scientific conference: thoughtful, unscripted, curious, and grounded in real-world experience. We bring listeners inside the decisions, discoveries, and personal journeys behind the therapies and technologies that may one day reduce suffering and improve lives.

Publisher

Gregory Austin

Category

business · health & fitness · science

Language

en

Explicit

No

First episode

27 Nov 2023

Latest episode

2 Oct 2026

Latest episodes

61 episodes in the feed.

1. 

   2 Oct 2026

   Is AI Changing Scientists? The Future of Pharma with Dr. Rob Dodge

   Rob Dodge says AI has made him an expert Python programmer, even though he never took a class in it. But does having new capabilities change what it means to be a scientist? Dr. Chad Briscoe sits down with Dr. Robert “Rob” Dodge at the AAPS National Biotechnology Conference in San Diego to discuss how artificial intelligence and machine learning are changing pharmaceutical research. Thank you to our sponsors TruTechnologies provides real-time clinical trial oversight, helping research teams improve protocol adherence and protect biospecimen integrity. https://trutechnologies.ai/ (https://trutechnologies.ai/) Leucentra: Inspired by science, empowered by IT. https://leucentra.com/ (https://leucentra.com/) About the conversation Rob remembers when spreadsheets changed how scientists calculated and plotted their results. Today, AI helps him write code and investigate scientific data with less reliance on specialist programming support. He and Chad discuss where these tools are useful, where they fall short, and what scientists still need to bring to the work. Their conversation covers assay development, access to clinical data, scientific writing, and the challenges of using AI in regulated bioanalysis. Rob also shares his predictions for how machine learning could change established modeling approaches, including quantitative systems pharmacology and design of experiments. Throughout the discussion, he returns to a familiar principle: scientists still need to develop hypotheses, test them, and question their results. In this episode How scientists are using AI to write Python programs What advances in mass spectrometry mean for complex drug modalities Machine learning for assay improvement and clinical data analysis Why data quality and laboratory experience matter Validation and quality assurance challenges in regulated research Using AI to draft and review scientific documents How independent consultants and smaller teams can use AI as a resource Rob’s predictions for the next year in pharmaceutical science About Dr. Rob Dodge Robert “Rob” Dodge, PhD, is an independent bioanalytical consultant focused on artificial intelligence and machine learning in regulated bioanalysis. His more than 30 years in pharmaceutical science include biologics manufacturing, bioanalytical testing, and leadership roles at Bristol-Myers Squibb and Novartis. He co-founded Princeton Bio Lab and previously served as Director of Immunochemistry and Cell Biology at Pharmanet Development Group. Connect with Rob: https://www.linkedin.com/in/robert-dodge-phd/ (https://www.linkedin.com/in/robert-dodge-phd/) About BioTalk Unzipped Hosted by Gregory Austin and Dr. Chad Briscoe, BioTalk Unzipped uncovers the stories and science behind medical progress through conversations with scientists and leaders in biotechnology and drug development. Find more episodes: https://www.biotalkunzipped.com/ (https://www.biotalkunzipped.com/) Follow BioTalk Unzipped on your podcast app to hear new episodes as they’re released. If this conversation brings a colleague to mind, send it their way.

2. 

   11 Sept 2026

   Do Clinical Trials Take Too Much Blood? Patient-Centric Sampling with Joleen White

   Dr. Chad Briscoe interviews Dr. Joleen White about patient-centric sampling and how smaller blood samples can improve clinical trials and global health research.

3. 

   8 Aug 2026

   Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

   Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, explains to Gregory Austin why gene therapy manufacturing remains challenging, offering insights into overcoming scale-up hurdles.

Who has been a guest on BioTalk Unzipped

Names identified in recent episode analyses. Showing up to five guests.

• Joleen White
• Phillip Ramsey
• Tracy Ryan
• Lakshmi Amaravadi
• Daniel Reker

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

YouTube views

20,466

Score snapshot 15 Sept 2025

Apple Podcasts (US)

5.0 / 5

8 ratings

Spotify

5.0 / 5

4 ratings

Podcast Authority Score: 62 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

65

Social presence

0

YouTube

76

Engagement

71

Contact BioTalk Unzipped

Guest appearances

Does not typically book guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Questions about BioTalk Unzipped